{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:45:47Z","timestamp":1788284747002,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY007092"],"award-info":[{"award-number":["EY007092"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY025154"],"award-info":[{"award-number":["EY025154"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY017045"],"award-info":[{"award-number":["EY017045"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY022097"],"award-info":[{"award-number":["EY022097"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY06360"],"award-info":[{"award-number":["EY06360"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.jconrel.2016.02.041","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T13:07:27Z","timestamp":1456664847000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma"],"prefix":"10.1016","volume":"228","author":[{"given":"B.","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Doty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.E.","family":"Grossniklaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.02.041_bb0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0010","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.ophtha.2013.04.027","article-title":"The cost of glaucoma care provided to Medicare beneficiaries from 2002 to 2009","volume":"120","author":"Quigley","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0015","series-title":"Duane's Ophthalmology","author":"Tasman","year":"2009"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0020","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pharmaceutics4010197","article-title":"Ocular drug delivery for glaucoma management","volume":"4","author":"Gooch","year":"2012","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0030","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma","volume":"25","author":"Lavik","year":"2011","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.bioeng.6.040803.140055","article-title":"Ocular biomechanics and biotransport","volume":"6","author":"Ethier","year":"2004","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2008.12.012","article-title":"Uveoscleral outflow\u2014a review","volume":"88","author":"Alm","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0060","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archopht.1995.01100120044006","article-title":"Effects of brimonidine on aqueous humor dynamics in human eyes","volume":"113","author":"Toris","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9394(01)00834-0","article-title":"Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma","volume":"131","author":"Konstas","year":"2001","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin","year":"2007","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","article-title":"Compliance barriers in glaucoma: a systematic classification","volume":"12","author":"Tsai","year":"2003","journal-title":"J. Glaucoma"},{"issue":"Pt 2","key":"10.1016\/j.jconrel.2016.02.041_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/eye.1998.56","article-title":"Compliance with timolol treatment in glaucoma","volume":"12","author":"Rotchford","year":"1998","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0085","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0090","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2105\/AJPH.83.5.711","article-title":"Treatment for glaucoma: adherence by the elderly","volume":"83","author":"Gurwitz","year":"1993","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.4.3.12","article-title":"Natural bioadhesive biodegradable nanoparticle-based topical ophthalmic formulations for management of glaucoma","volume":"4","author":"Ibrahim","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.exer.2014.06.013","article-title":"28-Day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres","volume":"125","author":"Fedorchak","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0105","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1111\/j.1755-3768.2012.02418.x","article-title":"Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes","volume":"90","author":"Deokule","year":"2012","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/02652040309178075","article-title":"Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery","volume":"20","author":"De","year":"2003","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0115","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/adhm.201300696","article-title":"Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye","volume":"3","author":"Kim","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/jop.2013.0063","article-title":"Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model","volume":"29","author":"Abarca","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0125","first-page":"1198","article-title":"Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes","volume":"19","author":"Kadam","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0130","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1167\/iovs.13-11747","article-title":"Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles","volume":"54","author":"Gilger","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0135","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/mp300716t","article-title":"Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab","volume":"10","author":"Tyagi","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0140","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0145","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/IAE.0b013e3182576d1d","article-title":"Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits","volume":"32","author":"Wang","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0150","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1167\/iovs.11-7525","article-title":"Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes","volume":"52","author":"Seiler","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0155","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1167\/iovs.10-6291","article-title":"Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model","volume":"52","author":"Olsen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow microneedles","volume":"28","author":"Patel","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017140","article-title":"Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter","volume":"6","author":"Peden","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0170","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1167\/iovs.06-0670","article-title":"Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging","volume":"48","author":"Kim","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ajo.2006.05.045","article-title":"Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment","volume":"142","author":"Olsen","year":"2006","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0180","first-page":"1533","article-title":"Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye","volume":"43","author":"Einmahl","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0185","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.14-14651","article-title":"Targeted delivery of anti-glaucoma drugs to the supraciliary space using microneedles","author":"Kim","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0190","first-page":"3557","article-title":"A phase 1\/2 open-label, safety and tolerability study of triamcinolone acetonide administered to the suprachoroidal space in patients with non-infectious uveitis","volume":"56","author":"Goldstein","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0195","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1167\/iovs.13-13707","article-title":"Drug and gene delivery to the back of the eye: from bench to bedside","volume":"55","author":"Rowe-Rendleman","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0200","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0039-6257(96)82028-5","article-title":"Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies","volume":"41","author":"Walters","year":"1996","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0205","doi-asserted-by":"crossref","first-page":"7387","DOI":"10.1167\/iovs.14-14651","article-title":"Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles","volume":"55","author":"Kim","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0210","unstructured":"M. Yamamoto, H. Okada, Y. Ogawa, T. Miyagawa, Polymer, production and use thereof, European Patent 86303417, (Oct. 21, 1987)."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0215","unstructured":"J.A. Burke, P.M. Hughes, K.-M. Zhang, T. Lin, G. Huang, B.A. Jackson, L.A. Wheeler, R.S. Donn, Intraocular implants and methods for improving vision, U.S. Patent US8293741 (2012)."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000267170","article-title":"Localization of alpha-2 adrenergic receptors in the human eye","volume":"24","author":"Matsuo","year":"1992","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0225","unstructured":"J. Chang, P. Hughes, Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems, U.S. Patent 7589057, (Sep. 15, 2009)."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0235","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejpb.2015.05.020","article-title":"Formulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedles","volume":"95","author":"Kim","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2015.02.021","article-title":"Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model","volume":"203","author":"Chen","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0245","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1167\/iovs.15-16597","article-title":"Real-time monitoring of suprachoroidal space (SCS) following SCS injection using ultra-high resolution optical coherence tomography in guinea pig eyes","volume":"56","author":"Gu","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1749-6632.1995.tb32392.x","article-title":"Adrenergic and imidazoline receptor-mediated responses to UK-14304-18 (brimonidine) in rabbits and monkeys. A species difference","volume":"763","author":"Burke","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0255","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2044.1999.00659.x","article-title":"Alpha-2 and imidazoline receptor agonists: their pharmacology and therapeutic role","volume":"54","author":"Khan","year":"1999","journal-title":"Anaesthesia"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2016.02.041_bb0260","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0039-6257(03)00003-1","article-title":"Targeting outflow facility in glaucoma management","volume":"48","author":"Brubaker","year":"2003","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0265","first-page":"793","article-title":"Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey","volume":"15","author":"Kaufman","year":"1976","journal-title":"Investig. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0270","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s004170050157","article-title":"Wound healing of scleral self-sealing incision: a comparison of ultrasound biomicroscopy and histology findings","volume":"236","author":"Hikichi","year":"1998","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0280","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/026520400417630","article-title":"In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters","volume":"17","author":"Lin","year":"2000","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0285","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-199915050-00005","article-title":"Efficacy and adverse effects of medications used in the treatment of glaucoma","volume":"15","author":"Camras","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0290","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajhp\/62.7.691","article-title":"Glaucoma and its treatment: a review","volume":"62","author":"Lee","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0295","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/PPA.S23780","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0300","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1016\/j.biomaterials.2011.03.062","article-title":"Intraocular degradation behavior of crosslinked and linear poly(trimethylene carbonate) and poly(d,l-lactic acid)","volume":"32","author":"Jansen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0305","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/jbm.a.10121","article-title":"In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with d,l-lactide or \u03f5-caprolactone: degradation and tissue response","volume":"67A","author":"P\u00eago","year":"2003","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0310","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2014.06.043","article-title":"Ocular delivery of macromolecules","volume":"190","author":"Kim","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0315","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.drudis.2014.10.010","article-title":"The suprachoroidal pathway: a new drug delivery route to the back of the eye","volume":"20","author":"Rai Udo","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0320","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3928\/23258160-20140306-09","article-title":"Active aspiration of suprachoroidal hemorrhage using a guarded needle","volume":"45","author":"Mandelcorn","year":"2014","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0325","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jcrs.2014.03.022","article-title":"Anatomic and physiologic rationale to be applied in accessing the suprachoroidal space for management of glaucoma","volume":"40","author":"Patrianakos","year":"2014","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0330","series-title":"Suprachoroidal Space as a Therapeutic Target","author":"Ianchulev","year":"2014"},{"key":"10.1016\/j.jconrel.2016.02.041_bb0335","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jcrs.2012.10.040","article-title":"Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery","volume":"39","author":"Hoeh","year":"2013","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.jconrel.2016.02.041_bb0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3928\/23258160-20130503-14","article-title":"Suprachoroidal silicone oil migration following retinal detachment repair","volume":"44","author":"Danylkova","year":"2013","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916301055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T08:49:05Z","timestamp":1572425345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916301055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":68,"alternative-id":["S0168365916301055"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}